{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:17:46Z","timestamp":1786997866995,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.vaccine.2023.06.089","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:55:45Z","timestamp":1692060945000},"page":"5820-5824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Optimal site of care for administration of extended half-life respiratory syncytial virus (RSV) antibodies to infants in the United States (US)"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1046-7635","authenticated-orcid":false,"given":"Christopher B.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenna L.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn R.","family":"Lew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William La","family":"Via","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.06.089_b0005","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/infdis\/jiac120","article-title":"Respiratory syncytial virus is the leading cause of United States infant hospitalizations, 2009\u20132019: a study of the national (nationwide) inpatient sample","volume":"226","author":"Suh","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.089_b0010","unstructured":"Centers for Disease Control and Prevention. CDC HAN-00443: Increased Interseasonal Respiratory Syncytial Virus (RSV) Activity in Parts of the Southern United States, https:\/\/emergency.cdc.gov\/han\/2021\/han00443.asp [accessed 20 December 2022]."},{"key":"10.1016\/j.vaccine.2023.06.089_b0015","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1093\/infdis\/jiac220","article-title":"Respiratory syncytial virus during the COVID-19 pandemic compared to historic levels: a retrospective cohort study of a health system","volume":"226","author":"Movva","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.089_b0020","unstructured":"Centers for Disease Control and Prevention. CDC HAN-00479: Increased Respiratory Virus Activity, Especially Among Children, Early in the 2022-2023 Fall and Winter, https:\/\/emergency.cdc.gov\/han\/2022\/han00479.asp [accessed 20 December 2022]."},{"key":"10.1016\/j.vaccine.2023.06.089_b0025","unstructured":"Wood C, Walter E, Espinosa C, Enriquez-Bruce M, Budhecha S, Elliott A, et al. Infant hospitalizations and ICU admissions for bronchiolitis and RSV-bronchiolitis are at historic highs during 2022 early seasonal disease: results from four US health systems. The Pediatric Academic Societies (PAS) Meeting, April 27 \u2013 May 1, 2023. Washington, D.C. USA."},{"key":"10.1016\/j.vaccine.2023.06.089_b0030","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/INF.0000000000001916","article-title":"Safety, tolerability and pharmacokinetics of MEDI8897, an extended half-life single-dose respiratory syncytial virus prefusion F-targeting monoclonal antibody administered as a single dose to healthy preterm infants","volume":"37","author":"Domachowske","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.06.089_b0035","unstructured":"European Medicines Agency. Beyfortus (nirsevimab): EPAR \u2013 Product Information; November 2022, https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/beyfortus [accessed 20 December 2022]."},{"key":"10.1016\/j.vaccine.2023.06.089_b0040","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Single-dose nirsevimab for prevention of RSV in preterm infants","volume":"383","author":"Griffin","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2023.06.089_b0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2352-4642(22)00321-2","volume":"7","author":"Sim\u00f5es","year":"2023","journal-title":"Lancet Child Adolesc"},{"key":"10.1016\/j.vaccine.2023.06.089_b0050","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1093\/infdis\/jiac155","article-title":"Respiratory syncytial virus burden and healthcare utilization in United States infants <1 year of age: study of nationally representative databases, 2011\u20132019","volume":"226","author":"Suh","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.089_b0055","series-title":"Bright futures: guidelines for health supervision of infants, children and adolescents","year":"2017"},{"key":"10.1016\/j.vaccine.2023.06.089_b0060","unstructured":"American Academy of Pediatrics. Bright Futures\/AAP Recommendations for Preventive Pediatric Health Care (periodicity schedule), https:\/\/www.aap.org\/periodicityschedule [accessed 20 December 2022]."},{"key":"10.1016\/j.vaccine.2023.06.089_b0065","unstructured":"American Academy of Pediatrics. AAP Schedule of Well-Child Care Visits, https:\/\/www.healthychildren.org\/English\/family-life\/health-management\/Pages\/Well-Child-Care-A-Check-Up-for-Success.aspx [accessed 20 December 2022]."},{"key":"10.1016\/j.vaccine.2023.06.089_b0070","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jamapediatrics.2022.2954","article-title":"Well-child visit adherence","volume":"176","author":"Abdus","year":"2022","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2023.06.089_b0075","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1542\/peds.2014-2329","article-title":"Timing of initial well-child visit and readmissions of newborns","volume":"135","author":"Shakib","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2023.06.089_b0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.acap.2013.09.009","article-title":"Factors associated with timing of first outpatient visit after newborn hospital discharge","volume":"14","author":"O'Donnell","year":"2014","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.vaccine.2023.06.089_b0085","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.2008-2926","article-title":"Delayed pediatric office follow-up of newborns after birth hospitalization","volume":"124","author":"Profit","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2023.06.089_b0090","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1542\/peds.113.6.1619","article-title":"Impact of early newborn discharge legislation and early follow-up visits on infant outcomes in a state Medicaid population","volume":"113","author":"Meara","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2023.06.089_b0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.jp.7210845","article-title":"Patient compliance with the first newborn visit appointment","volume":"23","author":"Feinberg","year":"2003","journal-title":"J Perinatol"},{"key":"10.1016\/j.vaccine.2023.06.089_b0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.15585\/mmwr.mm6702a4","article-title":"Respiratory syncytial virus seasonality - United States, 2014\u20132017","volume":"67","author":"Rose","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2023.06.089_b0105","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/irv.12885","article-title":"Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries","volume":"15","author":"Staadegaard","year":"2021","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2023.06.089_b0110","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1377\/hlthaff.2012.0691","article-title":"Adherence with recommended well-child visits has grown, but large gaps persist among various socioeconomic groups","volume":"32","author":"Abdus","year":"2013","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.vaccine.2023.06.089_b0115","doi-asserted-by":"crossref","first-page":"e1766","DOI":"10.1542\/peds.2006-0286","article-title":"Compliance with well-child visit recommendations: evidence from the Medical Expenditure Panel Survey, 2000\u20132002","volume":"118","author":"Selden","year":"2006","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23008022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23008022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:29:08Z","timestamp":1759404548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23008022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":23,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0264410X23008022"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal site of care for administration of extended half-life respiratory syncytial virus (RSV) antibodies to infants in the United States (US)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}